Sanofi Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001121404

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q1 2025 · 9 positions · Total reported value $165.94M · Top-10 concentration 100.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 37.5% · 6 new · 0 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -5.4% · vs SPY -7.6% · Prev Value $534.04M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -10.9% · vs SPY -13.1% · Latest Value $629.87M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q1 2025 13F filing, Sanofi disclosed 9 equity positions with a combined reported value of $165.94M. The filing implies a focused portfolio: its ten largest positions account for 100.0% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q1 2025 were MGTX ($82.70M), NVAX ($44.10M), INBX ($16.20M). By sector, the heaviest allocations are Health Care 97.3%, Other 2.7%. Versus the prior quarter, allocation shifted toward Health Care (+4.1pp) and away from Other (-4.1pp).

Versus the prior quarter, Sanofi opened 6 new positions, trimmed 0 and fully exited 0, a turnover rate of 37.5% of positions. The portfolio's overlap with the prior quarter was 100% of names.

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

Insider Transactions (Form 4)

Latest Sanofi buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

Transaction date Activity Security Shares Price Filing
2026-08-10 Conversion Latigo Biotherapeutics, Inc. 177,978 — SEC filing
2026-08-10 Conversion Latigo Biotherapeutics, Inc. 494,800 — SEC filing
2026-08-06 Buy Attovia Therapeutics, Inc. 300,000 $17.00 SEC filing
2026-08-06 Conversion Attovia Therapeutics, Inc. 782,855 — SEC filing

All insider transactions →

Fund Profile

Sanofi is an SEC-registered 13F filer. As of Q2 2026 it reported 10 US equity positions with a combined value of $534.04M. HoldingsHub carries 7 quarters of its filings (Q4 2024–Q2 2026).

Portfolio Structure

  • 10 positions · $534.04M reported value (Q2 2026)
  • Top 10 holdings = 100.0% of reported value
  • Largest position: MGTX (MEIRAGTX HLDGS PLC COM) at 30.9%
  • Average position size: $53.40M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 2 new, 1 exited
  • 8 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 97.3%
Other 2.7%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 12.20M $82.70M 49.84%
49.84%
Hold
2 6.88M $44.10M 26.58%
26.58%
Hold
3 1.16M $16.20M 9.76%
9.76%
Hold
4 821.92K $15.28M 9.21%
9.21%
Hold
5 814.98K $2.76M 1.67%
1.67%
Hold
6 1.92M $2.44M 1.47%
1.47%
Hold
7 1.44M $1.65M 1.00%
1.00%
Hold
8 443.25K $403.36K 0.24%
0.24%
Hold
9 244.08K $402.74K 0.24%
0.24%
Hold

FAQ

What did Sanofi buy in 2025-Q1?

In its 2025-Q1 13F filing, Sanofi reported 9 equity positions worth $165.94M in aggregate; its largest disclosed positions were MGTX ($82.70M), NVAX ($44.10M), INBX ($16.20M).

How large is Sanofi's portfolio?

Sanofi reported $165.94M of long equity holdings across 9 positions as of 2025-Q1. Top-10 holdings account for 100.0% of reported value.

What is Sanofi's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/sanofi/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →